SYNTHESIS, BENZODIAZEPINE RECEPTOR AFFINITY AND IN-VIVO TESTING OF -ALKYLPYRAZOL-3'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE OR 5'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE

Citation
S. Selleri et al., SYNTHESIS, BENZODIAZEPINE RECEPTOR AFFINITY AND IN-VIVO TESTING OF -ALKYLPYRAZOL-3'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE OR 5'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE, European journal of medicinal chemistry, 32(12), 1997, pp. 941-953
Citations number
36
Categorie Soggetti
Chemistry Medicinal
ISSN journal
02235234
Volume
32
Issue
12
Year of publication
1997
Pages
941 - 953
Database
ISI
SICI code
0223-5234(1997)32:12<941:SBRAAI>2.0.ZU;2-N
Abstract
The synthesis of a series of 3-aryl-4,7-dihydro-6-(N-1'-alkylpyrazol-3 or 5'-yl)pyrazolo[1,5-a]pyrimidin-7-ones and their in vitro biologica l evaluation as ligands for benzodiazepine receptor (BzR) are describe d. The in vitro activities, as determined by an analysis of GABA (gamm a-aminobutyric acid) shift ratios, and binding affinities of these com pounds to BzR are compared in terms of the electronic, lipophilic and steric effect changes of their substituents either at the 3-position o r at the N-1' of 6-(pyrazol-3'(5')-yl) moiety. The most interesting co mpounds were tested in vivo.